ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.

Monk BJ, Coleman RL, Fujiwara K, Wilson MK, Oza AM, Oaknin A, O'Malley DM, Lorusso D, Westin SN, Safra T, Herzog TJ, Marmé F, N Eskander R, Lin KK, Shih D, Goble S, Grechko N, Hume S, Maloney L, McNeish IA, Kristeleit RS

Open source

DOI: 10.1136/ijgc-2021-002933
Published: 2021 Dec
Container: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/ijgc-2021-002933,
  title = {ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.},
  author = {Monk BJ and Coleman RL and Fujiwara K and Wilson MK and Oza AM and Oaknin A and O'Malley DM and Lorusso D and Westin SN and Safra T and Herzog TJ and Marmé F and N Eskander R and Lin KK and Shih D and Goble S and Grechko N and Hume S and Maloney L and McNeish IA and Kristeleit RS},
  year = {2021},
  journal = {International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  doi = {10.1136/ijgc-2021-002933},
  url = {https://doi.org/10.1136/ijgc-2021-002933}
}

RIS

TY  - JOUR
TI  - ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
AU  - Monk BJ
AU  - Coleman RL
AU  - Fujiwara K
AU  - Wilson MK
AU  - Oza AM
AU  - Oaknin A
AU  - O'Malley DM
AU  - Lorusso D
AU  - Westin SN
AU  - Safra T
AU  - Herzog TJ
AU  - Marmé F
AU  - N Eskander R
AU  - Lin KK
AU  - Shih D
AU  - Goble S
AU  - Grechko N
AU  - Hume S
AU  - Maloney L
AU  - McNeish IA
AU  - Kristeleit RS
PY  - 2021
JO  - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
DO  - 10.1136/ijgc-2021-002933
UR  - https://doi.org/10.1136/ijgc-2021-002933
ER  -

APA

BJ, M., RL, C., K, F., MK, W., AM, O., A, O., DM, O., D, L., SN, W., T, S., TJ, H., F, M., R, N. E., KK, L., D, S., S, G., N, G., S, H., L, M., IA, M., & RS, K. (2021). ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. https://doi.org/10.1136/ijgc-2021-002933

Source records

pubmed · retrieved 2026-09-26T10:39:32.948Z